Genes encoding Pir51, Beclin 1, RbAp48 and aldolase b are up or down-regulated in human primary hepatocellular carcinoma
- PMID:14966907
- PMCID: PMC4716970
- DOI: 10.3748/wjg.v10.i4.509
Genes encoding Pir51, Beclin 1, RbAp48 and aldolase b are up or down-regulated in human primary hepatocellular carcinoma
Abstract
Aim: To reveal new tumor markers and target genes from differentially expressed genes of primary tumor samples using cDNA microarray.
Methods: The (33 )P labeled cDNAs were synthesized by reverse transcription of message RNA from the liver cancerous tissue and adjacent non-cancerous liver tissue from the same patient and used to hybridize to LifeGrid 1.0 cDNA microarray blot containing 8400 known and unique human cDNA gene targets, and an expression profile of genes was produced in one paired human liver tumor tissue. After a global analysis of gene expression of 8400 genes, we selected some genes to confirm the differential expression using Northern blot and RT-PCR.
Results: Parallel analysis of the hybridized signals enabled us to get an expression profile of genes in which about 500 genes were differentially expressed in the paired liver tumor tissues. We identified 4 genes, the expression of three (Beclin 1, RbAp48 and Pir51) were increased and one (aldolase b) was decreased in liver tumor tissues. In addition, the expression of these genes in 6 hepatoma cell lines was also showed by RT-PCR analysis.
Conclusion: cDNA microarray permits a high throughput identification of changes in gene expression. The genes encoding Beclin 1, RbAp48, Pir51 and aldolase b are first reported that may be related with hepatocarcinoma.
Figures



Similar articles
- Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma.Xu L, Hui L, Wang S, Gong J, Jin Y, Wang Y, Ji Y, Wu X, Han Z, Hu G.Xu L, et al.Cancer Res. 2001 Apr 1;61(7):3176-81.Cancer Res. 2001.PMID:11306505
- Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.Dong-Dong L, Xi-Ran Z.Dong-Dong L, et al.Hepatogastroenterology. 2004 Mar-Apr;51(56):515-25.Hepatogastroenterology. 2004.PMID:15086194
- Expression of cell cycle/growth regulator genes in human hepatocellular carcinoma and adjacent normal liver tissues.Liu LX, Jiang HC, Liu ZH, Zhu AL, Zhang WH, Wu LF, Zhou J, Wang XQ, Wu M.Liu LX, et al.Oncol Rep. 2003 Nov-Dec;10(6):1771-5.Oncol Rep. 2003.PMID:14534694
- Gene expression profiles of hepatoma cell line BEL-7402.Liu LX, Jiang HC, Liu ZH, Zhu AL, Zhou J, Zhang WH, Wang XQ, Wu M.Liu LX, et al.Hepatogastroenterology. 2003 Sep-Oct;50(53):1496-501.Hepatogastroenterology. 2003.PMID:14571772
- Differential gene expression in human hepatocellular carcinoma Hep3B cells induced by apoptosis-related gene BNIPL-2.Xie L, Qin WX, He XH, Shu HQ, Yao GF, Wan DF, Gu JR.Xie L, et al.World J Gastroenterol. 2004 May 1;10(9):1286-91. doi: 10.3748/wjg.v10.i9.1286.World J Gastroenterol. 2004.PMID:15112343Free PMC article.
Cited by
- RBBP4: A novel diagnostic and prognostic biomarker for non-small-cell lung cancer correlated with autophagic cell death.Zhan Y, Zhang Z, Yin A, Su X, Tang N, Chen Y, Zhang Z, Chen W, Wang J, Wang W.Zhan Y, et al.Cancer Med. 2024 Aug;13(15):e70090. doi: 10.1002/cam4.70090.Cancer Med. 2024.PMID:39109577Free PMC article.
- Autophagy and apoptosis-related genes in chronic liver disease and hepatocellular carcinoma.Kotsafti A, Farinati F, Cardin R, Cillo U, Nitti D, Bortolami M.Kotsafti A, et al.BMC Gastroenterol. 2012 Aug 28;12:118. doi: 10.1186/1471-230X-12-118.BMC Gastroenterol. 2012.PMID:22928777Free PMC article.
- Challenging, Accurate and Feasible: CAF-1 as a Tumour Proliferation Marker of Diagnostic and Prognostic Value.Sykaras AG, Pergaris A, Theocharis S.Sykaras AG, et al.Cancers (Basel). 2021 May 24;13(11):2575. doi: 10.3390/cancers13112575.Cancers (Basel). 2021.PMID:34073937Free PMC article.Review.
- Nitric oxide, mitochondrial hyperpolarization, and T cell activation.Nagy G, Koncz A, Fernandez D, Perl A.Nagy G, et al.Free Radic Biol Med. 2007 Jun 1;42(11):1625-31. doi: 10.1016/j.freeradbiomed.2007.02.026. Epub 2007 Mar 3.Free Radic Biol Med. 2007.PMID:17462531Free PMC article.Review.
- Gene expression analysis of primary normal human hepatocytes infected with human hepatitis B virus.Ryu HM, Park SG, Yea SS, Jang WH, Yang YI, Jung G.Ryu HM, et al.World J Gastroenterol. 2006 Aug 21;12(31):4986-95. doi: 10.3748/wjg.v12.i31.4986.World J Gastroenterol. 2006.PMID:16937494Free PMC article.
References
- Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol. 1997;12:S294–S308. - PubMed
- Naka T, Toyota N, Kaneko T, Kaibara N. Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma. Anticancer Res. 1998;18:555–564. - PubMed
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases